comparemela.com

Latest Breaking News On - Precision timed release - Page 3 : comparemela.com

CING Stock Price | Cingulate Inc Stock Quote (U S : Nasdaq)

CING | Complete Cingulate Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Matthewn bramsShanej schafferCraig steven gilgallonRaulr silvaCingulate incPrecision timed releaseHyperactivity disorderKansas cityIng analyst estimatesIng earnings estimatesIng share estimatesIng analyst recommendationsIng ratingsIngulate inc analyst estimatesIngulate inc earnings estimatesIngulate inc analyst recommendations

Cingulate (CING) Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103

Cingulate (CING) Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShanej schafferCingulate incDrug administrationPrecision timed releaseInvestigational new drugCingulate chairman

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) Cingulate Inc. CING, a biopharmaceutical company utilizing its proprietary Precision Timed Release™…

United statesDrug administrationCingulate incPrecision timed releaseReaking news

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United statesKansas cityThomas daltonMelyssa weibleShanej schafferMatt krepsPlatform technologyNational alliance on mental illnessPublic healthElixir health public relationsSecurities exchangeDarrow associatesExchange commissionDrug administrationCingulate incPrecision timed release

Cingulate Shares Fall to 52-Week Low After Reverse Split

By Josh Beckerman Shares of Cingulate, which is developing drugs using its Precision Timed Release technology, fell to a 52-week low after a 1-for-20 reverse.

Josh beckermanPrecision timed releasePermanent product measureArticle normalAnti depressantsHealthcare life sciencesSpecialized drugs medicationsCorporate fundingShare capitalCorporate actionsCorporate industrial newsReverse stock splitsStock splits bonus issuesEquity marketsCommodity financial market newsContent types

vimarsana © 2020. All Rights Reserved.